Review





Similar Products

94
ATCC 1 10e 48 serine threonine protein kinase scaffold 13
1 10e 48 Serine Threonine Protein Kinase Scaffold 13, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/1 10e 48 serine threonine protein kinase scaffold 13/product/ATCC
Average 94 stars, based on 1 article reviews
1 10e 48 serine threonine protein kinase scaffold 13 - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

90
Thermo Fisher blocking solution 37578
Blocking Solution 37578, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/blocking solution 37578/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
blocking solution 37578 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Thermo Fisher phospho-foxo3 (ser253) #pa5-37578 antibody
Evaluation of MuRF1 ( A ), MAFbx ( B ), ubiquitin ( C ), and TFEB ( D ) mRNA expression and <t>phospho-FOXO3</t> ( E ) content in the muscles of control (3C), three-day unloaded (3HS), and LY294002-treated three-day unloaded (3LY) rats. Phosphorylated FOXO3 content was normalized to the total FOXO3 content in each sample ( E ). N = 8. * indicates a significant difference from the control, and # indicates a significant difference from the 3HS group, p < 0.05.
Phospho Foxo3 (Ser253) #Pa5 37578 Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phospho-foxo3 (ser253) #pa5-37578 antibody/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
phospho-foxo3 (ser253) #pa5-37578 antibody - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

92
Santa Cruz Biotechnology cdk3
Figure 8 Proposed model for PTP1B regulation of cell cycle. PTP1B dephosphorylates and activates <t>Cdk3,</t> which in turn phosphorylates Rb, favoring its dissociation from E2F and promoting the expression of genes needed for the progression to S phase.
Cdk3, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cdk3/product/Santa Cruz Biotechnology
Average 92 stars, based on 1 article reviews
cdk3 - by Bioz Stars, 2026-02
92/100 stars
  Buy from Supplier

92
Santa Cruz Biotechnology human ptp1b
Schematic illustration of the SILAC-based quantitative phosphoproteomic approach. (A) Representative Western blot of <t>Ptp1b</t> +/+ and Ptp1b −/− cells. (B) Ptp1b +/+ and Ptp1b −/− cells were cultured in “light” (red) or “heavy” (blue) medium and stimulated with EGF for 15 min. After lysis, the samples were mixed and incubated with antiphosphotyrosine antibodies for enrichment of tyrosine-phosphorylated proteins. Then, the phosphoprotein fraction was digested with trypsin, and phosphopeptides were enriched again with TiO 2 beads. Phosphopeptides were analyzed by LC-MS/MS. (C) Proteins identified in this assay were classified according to their cellular function.
Human Ptp1b, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human ptp1b/product/Santa Cruz Biotechnology
Average 92 stars, based on 1 article reviews
human ptp1b - by Bioz Stars, 2026-02
92/100 stars
  Buy from Supplier

92
Santa Cruz Biotechnology cdk3 af rev
Identification of cell cycle related substrates of PTP1B
Cdk3 Af Rev, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cdk3 af rev/product/Santa Cruz Biotechnology
Average 92 stars, based on 1 article reviews
cdk3 af rev - by Bioz Stars, 2026-02
92/100 stars
  Buy from Supplier

92
Santa Cruz Biotechnology cdk3 af fwd
Identification of cell cycle related substrates of PTP1B
Cdk3 Af Fwd, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cdk3 af fwd/product/Santa Cruz Biotechnology
Average 92 stars, based on 1 article reviews
cdk3 af fwd - by Bioz Stars, 2026-02
92/100 stars
  Buy from Supplier

90
Thermo Fisher startingblock buffer pierce 37578
Identification of cell cycle related substrates of PTP1B
Startingblock Buffer Pierce 37578, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/startingblock buffer pierce 37578/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
startingblock buffer pierce 37578 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Thermo Fisher 1× startingblock buffer 37578
Identification of cell cycle related substrates of PTP1B
1× Startingblock Buffer 37578, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/1× startingblock buffer 37578/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
1× startingblock buffer 37578 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Evaluation of MuRF1 ( A ), MAFbx ( B ), ubiquitin ( C ), and TFEB ( D ) mRNA expression and phospho-FOXO3 ( E ) content in the muscles of control (3C), three-day unloaded (3HS), and LY294002-treated three-day unloaded (3LY) rats. Phosphorylated FOXO3 content was normalized to the total FOXO3 content in each sample ( E ). N = 8. * indicates a significant difference from the control, and # indicates a significant difference from the 3HS group, p < 0.05.

Journal: International Journal of Molecular Sciences

Article Title: Role of PI3 Kinases in Cell Signaling and Soleus Muscle Atrophy During Three Days of Unloading

doi: 10.3390/ijms26010414

Figure Lengend Snippet: Evaluation of MuRF1 ( A ), MAFbx ( B ), ubiquitin ( C ), and TFEB ( D ) mRNA expression and phospho-FOXO3 ( E ) content in the muscles of control (3C), three-day unloaded (3HS), and LY294002-treated three-day unloaded (3LY) rats. Phosphorylated FOXO3 content was normalized to the total FOXO3 content in each sample ( E ). N = 8. * indicates a significant difference from the control, and # indicates a significant difference from the 3HS group, p < 0.05.

Article Snippet: The following primary antibodies were used: IP3 receptors (1:500, #PA5-96855), phospho-CaMKII (Thr286) (1:500, #PA1-4614), phospho-FoxO3 (Ser253) (1:1000, #PA5-37578), and FoxO3 (1:1000, #PA5-20973) from Thermo Fisher Scientific, Waltham, MA, USA.

Techniques: Ubiquitin Proteomics, Expressing, Muscles, Control

Figure 8 Proposed model for PTP1B regulation of cell cycle. PTP1B dephosphorylates and activates Cdk3, which in turn phosphorylates Rb, favoring its dissociation from E2F and promoting the expression of genes needed for the progression to S phase.

Journal: Molecular and cellular biology

Article Title: A PTP1B-Cdk3 Signaling Axis Promotes Cell Cycle Progression of Human Glioblastoma Cells through an Rb-E2F Dependent Pathway.

doi: 10.1080/10985549.2023.2273193

Figure Lengend Snippet: Figure 8 Proposed model for PTP1B regulation of cell cycle. PTP1B dephosphorylates and activates Cdk3, which in turn phosphorylates Rb, favoring its dissociation from E2F and promoting the expression of genes needed for the progression to S phase.

Article Snippet: The primer sequences for mutagenesis were Cdk3AF Fwd: 50 aagatcggagagggcgcctttggggtggtgtacaa 30 and Cdk3AF Rev: 50 ttgtacaccaccccaaaggcgccctctccgatctt 30 . siRNAs targeting human PTP1B (sc-36328) and Cdk3 (sc-37578) were obtained from Santa Cruz (Dallas, TX, USA).

Techniques: Expressing

Schematic illustration of the SILAC-based quantitative phosphoproteomic approach. (A) Representative Western blot of Ptp1b +/+ and Ptp1b −/− cells. (B) Ptp1b +/+ and Ptp1b −/− cells were cultured in “light” (red) or “heavy” (blue) medium and stimulated with EGF for 15 min. After lysis, the samples were mixed and incubated with antiphosphotyrosine antibodies for enrichment of tyrosine-phosphorylated proteins. Then, the phosphoprotein fraction was digested with trypsin, and phosphopeptides were enriched again with TiO 2 beads. Phosphopeptides were analyzed by LC-MS/MS. (C) Proteins identified in this assay were classified according to their cellular function.

Journal: Molecular and Cellular Biology

Article Title: A PTP1B-Cdk3 Signaling Axis Promotes Cell Cycle Progression of Human Glioblastoma Cells through an Rb-E2F Dependent Pathway

doi: 10.1080/10985549.2023.2273193

Figure Lengend Snippet: Schematic illustration of the SILAC-based quantitative phosphoproteomic approach. (A) Representative Western blot of Ptp1b +/+ and Ptp1b −/− cells. (B) Ptp1b +/+ and Ptp1b −/− cells were cultured in “light” (red) or “heavy” (blue) medium and stimulated with EGF for 15 min. After lysis, the samples were mixed and incubated with antiphosphotyrosine antibodies for enrichment of tyrosine-phosphorylated proteins. Then, the phosphoprotein fraction was digested with trypsin, and phosphopeptides were enriched again with TiO 2 beads. Phosphopeptides were analyzed by LC-MS/MS. (C) Proteins identified in this assay were classified according to their cellular function.

Article Snippet: The primer sequences for mutagenesis were Cdk3 AF Fwd: 5′ aagatcggagagggc g cct t tggggtggtgtacaa 3′ and Cdk3 AF Rev: 5′ ttgtacaccacccca a agg c gccctctccgatctt 3′. siRNAs targeting human PTP1B (sc-36328) and Cdk3 (sc-37578) were obtained from Santa Cruz (Dallas, TX, USA).

Techniques: Multiplex sample analysis, Western Blot, Cell Culture, Lysis, Incubation, Liquid Chromatography with Mass Spectroscopy, Cell Function Assay

Predicted structure of PTP1B in complex with some of the putative substrates identified by SILAC-based phosphoproteomics. (A) Visualization of the complex of Cdk3 (yellow) and the catalytic domain of PTP1B (grey). The catalytic residue Cys215 of PTP1B and pTyr15 of Cdk are indicated in green and red, respectively. (B) Closer view of the PTP1B-Cdk3 interaction. The distance between pTyr15 of Cdk3 and Cys215 of PTP1B is indicated. (C) Visualization of the complex of IR β (yellow) and PTP1B (grey). The catalytic residue Cys215 indicated in green is close to IR β pTyr1146 indicated in red. (D) Closer view of the PTP1B-IR β interaction. The distance between Cdk3 pTyr1146 and PTP1B Cys215 is indicated. (E) Visualization of the complex of DOK1 (yellow) and PTP1B (grey). The catalytic residue Cys215 indicated in green is close to DOK1 pTyr362 indicated in red. (F) Closer view of the PTP1B-DOK1 interaction. The distance between DOK1 pTyr362 and PTP1B Cys215 is indicated.(G) Visualization of the complex of EphA (yellow) and PTP1B (gray). The catalytic residue Cys215 indicated in green is close to EphA pTyr205 indicated in red. (F) Closer view of the PTP1B-EphA interaction. The distance between EphA pTyr205 and PTP1B Cys215 is indicated.

Journal: Molecular and Cellular Biology

Article Title: A PTP1B-Cdk3 Signaling Axis Promotes Cell Cycle Progression of Human Glioblastoma Cells through an Rb-E2F Dependent Pathway

doi: 10.1080/10985549.2023.2273193

Figure Lengend Snippet: Predicted structure of PTP1B in complex with some of the putative substrates identified by SILAC-based phosphoproteomics. (A) Visualization of the complex of Cdk3 (yellow) and the catalytic domain of PTP1B (grey). The catalytic residue Cys215 of PTP1B and pTyr15 of Cdk are indicated in green and red, respectively. (B) Closer view of the PTP1B-Cdk3 interaction. The distance between pTyr15 of Cdk3 and Cys215 of PTP1B is indicated. (C) Visualization of the complex of IR β (yellow) and PTP1B (grey). The catalytic residue Cys215 indicated in green is close to IR β pTyr1146 indicated in red. (D) Closer view of the PTP1B-IR β interaction. The distance between Cdk3 pTyr1146 and PTP1B Cys215 is indicated. (E) Visualization of the complex of DOK1 (yellow) and PTP1B (grey). The catalytic residue Cys215 indicated in green is close to DOK1 pTyr362 indicated in red. (F) Closer view of the PTP1B-DOK1 interaction. The distance between DOK1 pTyr362 and PTP1B Cys215 is indicated.(G) Visualization of the complex of EphA (yellow) and PTP1B (gray). The catalytic residue Cys215 indicated in green is close to EphA pTyr205 indicated in red. (F) Closer view of the PTP1B-EphA interaction. The distance between EphA pTyr205 and PTP1B Cys215 is indicated.

Article Snippet: The primer sequences for mutagenesis were Cdk3 AF Fwd: 5′ aagatcggagagggc g cct t tggggtggtgtacaa 3′ and Cdk3 AF Rev: 5′ ttgtacaccacccca a agg c gccctctccgatctt 3′. siRNAs targeting human PTP1B (sc-36328) and Cdk3 (sc-37578) were obtained from Santa Cruz (Dallas, TX, USA).

Techniques: Multiplex sample analysis, Phospho-proteomics, Residue

Minimal distance from the catalytic residues on PTP1B’s phosphatase domain to the phosphorous atom of its substrates

Journal: Molecular and Cellular Biology

Article Title: A PTP1B-Cdk3 Signaling Axis Promotes Cell Cycle Progression of Human Glioblastoma Cells through an Rb-E2F Dependent Pathway

doi: 10.1080/10985549.2023.2273193

Figure Lengend Snippet: Minimal distance from the catalytic residues on PTP1B’s phosphatase domain to the phosphorous atom of its substrates

Article Snippet: The primer sequences for mutagenesis were Cdk3 AF Fwd: 5′ aagatcggagagggc g cct t tggggtggtgtacaa 3′ and Cdk3 AF Rev: 5′ ttgtacaccacccca a agg c gccctctccgatctt 3′. siRNAs targeting human PTP1B (sc-36328) and Cdk3 (sc-37578) were obtained from Santa Cruz (Dallas, TX, USA).

Techniques: Ligand Binding Assay

PTP1B dephosphorylates a Cdk3 derived peptide in vitro and both proteins interact in GB cells. (A) The in vitro activity of PTP1B against a phosphopeptide corresponding to residues 9-21 of Cdk3 (KIGEGT pY GVVYKA) was determined by using a malachite-green based assay. An IR β phosphopeptide (TRDI pY ETDYYRK) was used as positive control and the nonphosphorylated peptides of Cdk3 and IR β were used as negative controls. Each assay was independently repeated with four replicates and the nmol of phosphate released were calculated. Data are presented as means ± SE. (B). Assessment of Cdk3 activity in Ptp1b +/+ and Ptp1b −/− MEFs. Cell lysates were subjected to Western blot with anti-PTP1B, anti-Cdk3 or anti-phospho Cdk3 antibodies. GAPDH was used as loading control. (C) Co-immunoprecipitation of ectopically expressed wild-type or trapping mutant PTP1B and Cdk3. Cell lysates of transfected cells incubated with or without 1 mM of sodium orthovanadate were subjected to immunoprecipitation with anti-myc or isotype control IgG antibodies and the presence of Cdk3 in the complex was assessed with anti-HA antibodies. The presence of PTP1B and Cdk3 in cell extracts prior to immunoprecipitation was verified using specific antibodies (input). (D) Co-immunoprecipitation of endogenous PTP1B and Cdk3. LN229, U87-MG and U251 cell lysates were subjected to immunoprecipitation with anti-PTP1B or isotype control IgG antibodies and the presence of Cdk3 in the complex was assessed with anti-Cdk3 antibodies. The presence of PTP1B and Cdk3 in cell extracts prior to immunoprecipitation was verified using specific antibodies (input). (E) The physical interaction between endogenously expressed PTP1B and Cdk3 in LN229, U87-MG and U251 GB cells was determined using proximity ligation assays. The figure shows representative confocal microscopy images in which PTP1B-Cdk3 interactions appear as individual fluorescent red dots (lower panels). Anti-mouse and anti-rabbit isotype IgG antibodies were used as negative controls (upper panels).

Journal: Molecular and Cellular Biology

Article Title: A PTP1B-Cdk3 Signaling Axis Promotes Cell Cycle Progression of Human Glioblastoma Cells through an Rb-E2F Dependent Pathway

doi: 10.1080/10985549.2023.2273193

Figure Lengend Snippet: PTP1B dephosphorylates a Cdk3 derived peptide in vitro and both proteins interact in GB cells. (A) The in vitro activity of PTP1B against a phosphopeptide corresponding to residues 9-21 of Cdk3 (KIGEGT pY GVVYKA) was determined by using a malachite-green based assay. An IR β phosphopeptide (TRDI pY ETDYYRK) was used as positive control and the nonphosphorylated peptides of Cdk3 and IR β were used as negative controls. Each assay was independently repeated with four replicates and the nmol of phosphate released were calculated. Data are presented as means ± SE. (B). Assessment of Cdk3 activity in Ptp1b +/+ and Ptp1b −/− MEFs. Cell lysates were subjected to Western blot with anti-PTP1B, anti-Cdk3 or anti-phospho Cdk3 antibodies. GAPDH was used as loading control. (C) Co-immunoprecipitation of ectopically expressed wild-type or trapping mutant PTP1B and Cdk3. Cell lysates of transfected cells incubated with or without 1 mM of sodium orthovanadate were subjected to immunoprecipitation with anti-myc or isotype control IgG antibodies and the presence of Cdk3 in the complex was assessed with anti-HA antibodies. The presence of PTP1B and Cdk3 in cell extracts prior to immunoprecipitation was verified using specific antibodies (input). (D) Co-immunoprecipitation of endogenous PTP1B and Cdk3. LN229, U87-MG and U251 cell lysates were subjected to immunoprecipitation with anti-PTP1B or isotype control IgG antibodies and the presence of Cdk3 in the complex was assessed with anti-Cdk3 antibodies. The presence of PTP1B and Cdk3 in cell extracts prior to immunoprecipitation was verified using specific antibodies (input). (E) The physical interaction between endogenously expressed PTP1B and Cdk3 in LN229, U87-MG and U251 GB cells was determined using proximity ligation assays. The figure shows representative confocal microscopy images in which PTP1B-Cdk3 interactions appear as individual fluorescent red dots (lower panels). Anti-mouse and anti-rabbit isotype IgG antibodies were used as negative controls (upper panels).

Article Snippet: The primer sequences for mutagenesis were Cdk3 AF Fwd: 5′ aagatcggagagggc g cct t tggggtggtgtacaa 3′ and Cdk3 AF Rev: 5′ ttgtacaccacccca a agg c gccctctccgatctt 3′. siRNAs targeting human PTP1B (sc-36328) and Cdk3 (sc-37578) were obtained from Santa Cruz (Dallas, TX, USA).

Techniques: Derivative Assay, In Vitro, Activity Assay, Phospho-proteomics, Malachite Green Assay, Positive Control, Western Blot, Control, Immunoprecipitation, Mutagenesis, Transfection, Incubation, Ligation, Confocal Microscopy

PTP1B and Cdk3 depletion impairs cell proliferation. (A) GB cells were transfected with siRNAs targeting PTP1B or Cdk3, and the expression of both proteins was assessed by immunoblot. GAPDH was used as loading control. (B) GB cells were synchronized at G0 by serum deprivation and incubated 3 h with vehicle, claramine 2 µM, trodusquemine 2 µM, or transfected with nontargeting siRNAs or siRNAs targeting PTP1B or Cdk3. Cells were counted every 24 h. Proliferation of LN229, U87-MG and U251 cells is represented as mean ± SE of three independent experiments. (C) Ptp1b +/+ and Ptp1b −/− MEFs were synchronized at G0 by serum deprivation and incubated 3 h with vehicle, claramine 2 µM, trodusquemine 2 µM. Cells were counted every 24 h. Proliferation of Ptp1b +/+ and Ptp1b −/− MEFs is represented as mean ± SE of three independent experiments.

Journal: Molecular and Cellular Biology

Article Title: A PTP1B-Cdk3 Signaling Axis Promotes Cell Cycle Progression of Human Glioblastoma Cells through an Rb-E2F Dependent Pathway

doi: 10.1080/10985549.2023.2273193

Figure Lengend Snippet: PTP1B and Cdk3 depletion impairs cell proliferation. (A) GB cells were transfected with siRNAs targeting PTP1B or Cdk3, and the expression of both proteins was assessed by immunoblot. GAPDH was used as loading control. (B) GB cells were synchronized at G0 by serum deprivation and incubated 3 h with vehicle, claramine 2 µM, trodusquemine 2 µM, or transfected with nontargeting siRNAs or siRNAs targeting PTP1B or Cdk3. Cells were counted every 24 h. Proliferation of LN229, U87-MG and U251 cells is represented as mean ± SE of three independent experiments. (C) Ptp1b +/+ and Ptp1b −/− MEFs were synchronized at G0 by serum deprivation and incubated 3 h with vehicle, claramine 2 µM, trodusquemine 2 µM. Cells were counted every 24 h. Proliferation of Ptp1b +/+ and Ptp1b −/− MEFs is represented as mean ± SE of three independent experiments.

Article Snippet: The primer sequences for mutagenesis were Cdk3 AF Fwd: 5′ aagatcggagagggc g cct t tggggtggtgtacaa 3′ and Cdk3 AF Rev: 5′ ttgtacaccacccca a agg c gccctctccgatctt 3′. siRNAs targeting human PTP1B (sc-36328) and Cdk3 (sc-37578) were obtained from Santa Cruz (Dallas, TX, USA).

Techniques: Transfection, Expressing, Western Blot, Control, Incubation

PTP1B reduced activity impairs Cdk3 activation and induces cell cycle arrest in human GB cells. GB cells were synchronized at G0 by serum deprivation for 48 h and incubated 3 h with vehicle (A), claramine 2 µM (B), or trodusquemine 2 µM. Cell cycle arrest was released by the addition of 10% FBS and cells were collected at the indicated times. The activity of Cdk3 was assessed by immunoblot. GAPDH was used as loading control. (D) GB cells were synchronized at G0 and incubated 3 h with vehicle, claramine 2 µM or trodusquemine 2 µM as previously mentioned, or transfected with nontargeting siRNAs or siRNAs targeting PTP1B or Cdk3. Cell cycle arrest was released by the addition of 10% FBS, cells were fixed at indicated time points and stained with propidium iodide. Quantification of the percentage of cells at each phase is represented. Statistical differences between control and experimental groups of cells are indicated (* P < 0.05). Data are representative of three independent experiments.

Journal: Molecular and Cellular Biology

Article Title: A PTP1B-Cdk3 Signaling Axis Promotes Cell Cycle Progression of Human Glioblastoma Cells through an Rb-E2F Dependent Pathway

doi: 10.1080/10985549.2023.2273193

Figure Lengend Snippet: PTP1B reduced activity impairs Cdk3 activation and induces cell cycle arrest in human GB cells. GB cells were synchronized at G0 by serum deprivation for 48 h and incubated 3 h with vehicle (A), claramine 2 µM (B), or trodusquemine 2 µM. Cell cycle arrest was released by the addition of 10% FBS and cells were collected at the indicated times. The activity of Cdk3 was assessed by immunoblot. GAPDH was used as loading control. (D) GB cells were synchronized at G0 and incubated 3 h with vehicle, claramine 2 µM or trodusquemine 2 µM as previously mentioned, or transfected with nontargeting siRNAs or siRNAs targeting PTP1B or Cdk3. Cell cycle arrest was released by the addition of 10% FBS, cells were fixed at indicated time points and stained with propidium iodide. Quantification of the percentage of cells at each phase is represented. Statistical differences between control and experimental groups of cells are indicated (* P < 0.05). Data are representative of three independent experiments.

Article Snippet: The primer sequences for mutagenesis were Cdk3 AF Fwd: 5′ aagatcggagagggc g cct t tggggtggtgtacaa 3′ and Cdk3 AF Rev: 5′ ttgtacaccacccca a agg c gccctctccgatctt 3′. siRNAs targeting human PTP1B (sc-36328) and Cdk3 (sc-37578) were obtained from Santa Cruz (Dallas, TX, USA).

Techniques: Activity Assay, Activation Assay, Incubation, Western Blot, Control, Transfection, Staining

PTP1B reduced activity negatively affects Cdk3/Rb/E2F signaling in human GB cells. (A) The activities of Cdk3 and Rb in GB cells treated with vehicle, claramine 2 µM or trodusquemine 2 µM were assessed by immunoblot using total and phospho-specific antibodies. (B) The activities of Cdk3 and Rb in GB cells transfected with siRNAs targeting PTP1B were assessed by immunoblot using total and phospho-specific antibodies. (C) The expression levels of the E2F target genes: Cdk1, Cyclin A, and Cyclin E1 were assessed by RT-qPCR. All data were normalized to control GAPDH. Fold changes were calculated using the ΔCt method (2 -ΔΔCt ). Data are representative of three independent experiments.

Journal: Molecular and Cellular Biology

Article Title: A PTP1B-Cdk3 Signaling Axis Promotes Cell Cycle Progression of Human Glioblastoma Cells through an Rb-E2F Dependent Pathway

doi: 10.1080/10985549.2023.2273193

Figure Lengend Snippet: PTP1B reduced activity negatively affects Cdk3/Rb/E2F signaling in human GB cells. (A) The activities of Cdk3 and Rb in GB cells treated with vehicle, claramine 2 µM or trodusquemine 2 µM were assessed by immunoblot using total and phospho-specific antibodies. (B) The activities of Cdk3 and Rb in GB cells transfected with siRNAs targeting PTP1B were assessed by immunoblot using total and phospho-specific antibodies. (C) The expression levels of the E2F target genes: Cdk1, Cyclin A, and Cyclin E1 were assessed by RT-qPCR. All data were normalized to control GAPDH. Fold changes were calculated using the ΔCt method (2 -ΔΔCt ). Data are representative of three independent experiments.

Article Snippet: The primer sequences for mutagenesis were Cdk3 AF Fwd: 5′ aagatcggagagggc g cct t tggggtggtgtacaa 3′ and Cdk3 AF Rev: 5′ ttgtacaccacccca a agg c gccctctccgatctt 3′. siRNAs targeting human PTP1B (sc-36328) and Cdk3 (sc-37578) were obtained from Santa Cruz (Dallas, TX, USA).

Techniques: Activity Assay, Western Blot, Transfection, Expressing, Quantitative RT-PCR, Control

Activated Cdk3 bypasses requirement for PTP1B for proliferation and cell cycle progression. (A) GB cells were transfected with a plasmid encoding a constitutively active Cdk3 mutant. The presence of Cdk3 AF in cell extracts was verified by Western blot using anti-HA antibodies. (B) GB cells were mock transfected or transfected with a plasmid encoding a constitutively active Cdk3 mutant and incubated 3 h with vehicle, claramine 2 µM or trodusquemine 2 µM. Cells were counted every 24 h. Proliferation of LN229, U87-MG and U251 cells is represented as mean ± SE of three independent experiments. (C) GB cells were mock transfected or transfected with a plasmid encoding a constitutively active Cdk3 mutant, synchronized at G0 and incubated 3 h with vehicle, claramine 2 µM or trodusquemine 2 µM as previously described. Cell cycle arrest was released by the addition of 10% FBS, cells were fixed at indicated time points and stained with propidium iodide. Quantification of the percentage of cells at each phase is represented in the bar graphics. Statistical differences between control and experimental groups of cells are indicated (* P < 0.05). Data are representative of three independent experiments. (D) GB cells were mock transfected or transfected with a plasmid encoding a constitutively active Cdk3 mutant, synchronized at G0 and incubated 3 h with vehicle, claramine 2 µM or trodusquemine 2 µM as previously mentioned. Cell cycle arrest was released by the addition of 10% FBS. The expression levels of the E2F target genes: Cdk1, cyclin A, and cyclin E1 were assessed by RT-qPCR. All data were normalized to control GAPDH. Fold changes were calculated using the ΔCt method (2 -ΔΔCt ). Data are representative of three independent experiments.

Journal: Molecular and Cellular Biology

Article Title: A PTP1B-Cdk3 Signaling Axis Promotes Cell Cycle Progression of Human Glioblastoma Cells through an Rb-E2F Dependent Pathway

doi: 10.1080/10985549.2023.2273193

Figure Lengend Snippet: Activated Cdk3 bypasses requirement for PTP1B for proliferation and cell cycle progression. (A) GB cells were transfected with a plasmid encoding a constitutively active Cdk3 mutant. The presence of Cdk3 AF in cell extracts was verified by Western blot using anti-HA antibodies. (B) GB cells were mock transfected or transfected with a plasmid encoding a constitutively active Cdk3 mutant and incubated 3 h with vehicle, claramine 2 µM or trodusquemine 2 µM. Cells were counted every 24 h. Proliferation of LN229, U87-MG and U251 cells is represented as mean ± SE of three independent experiments. (C) GB cells were mock transfected or transfected with a plasmid encoding a constitutively active Cdk3 mutant, synchronized at G0 and incubated 3 h with vehicle, claramine 2 µM or trodusquemine 2 µM as previously described. Cell cycle arrest was released by the addition of 10% FBS, cells were fixed at indicated time points and stained with propidium iodide. Quantification of the percentage of cells at each phase is represented in the bar graphics. Statistical differences between control and experimental groups of cells are indicated (* P < 0.05). Data are representative of three independent experiments. (D) GB cells were mock transfected or transfected with a plasmid encoding a constitutively active Cdk3 mutant, synchronized at G0 and incubated 3 h with vehicle, claramine 2 µM or trodusquemine 2 µM as previously mentioned. Cell cycle arrest was released by the addition of 10% FBS. The expression levels of the E2F target genes: Cdk1, cyclin A, and cyclin E1 were assessed by RT-qPCR. All data were normalized to control GAPDH. Fold changes were calculated using the ΔCt method (2 -ΔΔCt ). Data are representative of three independent experiments.

Article Snippet: The primer sequences for mutagenesis were Cdk3 AF Fwd: 5′ aagatcggagagggc g cct t tggggtggtgtacaa 3′ and Cdk3 AF Rev: 5′ ttgtacaccacccca a agg c gccctctccgatctt 3′. siRNAs targeting human PTP1B (sc-36328) and Cdk3 (sc-37578) were obtained from Santa Cruz (Dallas, TX, USA).

Techniques: Transfection, Plasmid Preparation, Mutagenesis, Western Blot, Incubation, Staining, Control, Expressing, Quantitative RT-PCR

Proposed model for PTP1B regulation of cell cycle. PTP1B dephosphorylates and activates Cdk3, which in turn phosphorylates Rb, favoring its dissociation from E2F and promoting the expression of genes needed for the progression to S phase.

Journal: Molecular and Cellular Biology

Article Title: A PTP1B-Cdk3 Signaling Axis Promotes Cell Cycle Progression of Human Glioblastoma Cells through an Rb-E2F Dependent Pathway

doi: 10.1080/10985549.2023.2273193

Figure Lengend Snippet: Proposed model for PTP1B regulation of cell cycle. PTP1B dephosphorylates and activates Cdk3, which in turn phosphorylates Rb, favoring its dissociation from E2F and promoting the expression of genes needed for the progression to S phase.

Article Snippet: The primer sequences for mutagenesis were Cdk3 AF Fwd: 5′ aagatcggagagggc g cct t tggggtggtgtacaa 3′ and Cdk3 AF Rev: 5′ ttgtacaccacccca a agg c gccctctccgatctt 3′. siRNAs targeting human PTP1B (sc-36328) and Cdk3 (sc-37578) were obtained from Santa Cruz (Dallas, TX, USA).

Techniques: Expressing

Identification of cell cycle related substrates of PTP1B

Journal: Molecular and Cellular Biology

Article Title: A PTP1B-Cdk3 Signaling Axis Promotes Cell Cycle Progression of Human Glioblastoma Cells through an Rb-E2F Dependent Pathway

doi: 10.1080/10985549.2023.2273193

Figure Lengend Snippet: Identification of cell cycle related substrates of PTP1B

Article Snippet: The primer sequences for mutagenesis were Cdk3 AF Fwd: 5′ aagatcggagagggc g cct t tggggtggtgtacaa 3′ and Cdk3 AF Rev: 5′ ttgtacaccacccca a agg c gccctctccgatctt 3′. siRNAs targeting human PTP1B (sc-36328) and Cdk3 (sc-37578) were obtained from Santa Cruz (Dallas, TX, USA).

Techniques: Sequencing

Predicted structure of PTP1B in complex with some of the putative substrates identified by SILAC-based phosphoproteomics. (A) Visualization of the complex of Cdk3 (yellow) and the catalytic domain of PTP1B (grey). The catalytic residue Cys215 of PTP1B and pTyr15 of Cdk are indicated in green and red, respectively. (B) Closer view of the PTP1B-Cdk3 interaction. The distance between pTyr15 of Cdk3 and Cys215 of PTP1B is indicated. (C) Visualization of the complex of IR β (yellow) and PTP1B (grey). The catalytic residue Cys215 indicated in green is close to IR β pTyr1146 indicated in red. (D) Closer view of the PTP1B-IR β interaction. The distance between Cdk3 pTyr1146 and PTP1B Cys215 is indicated. (E) Visualization of the complex of DOK1 (yellow) and PTP1B (grey). The catalytic residue Cys215 indicated in green is close to DOK1 pTyr362 indicated in red. (F) Closer view of the PTP1B-DOK1 interaction. The distance between DOK1 pTyr362 and PTP1B Cys215 is indicated.(G) Visualization of the complex of EphA (yellow) and PTP1B (gray). The catalytic residue Cys215 indicated in green is close to EphA pTyr205 indicated in red. (F) Closer view of the PTP1B-EphA interaction. The distance between EphA pTyr205 and PTP1B Cys215 is indicated.

Journal: Molecular and Cellular Biology

Article Title: A PTP1B-Cdk3 Signaling Axis Promotes Cell Cycle Progression of Human Glioblastoma Cells through an Rb-E2F Dependent Pathway

doi: 10.1080/10985549.2023.2273193

Figure Lengend Snippet: Predicted structure of PTP1B in complex with some of the putative substrates identified by SILAC-based phosphoproteomics. (A) Visualization of the complex of Cdk3 (yellow) and the catalytic domain of PTP1B (grey). The catalytic residue Cys215 of PTP1B and pTyr15 of Cdk are indicated in green and red, respectively. (B) Closer view of the PTP1B-Cdk3 interaction. The distance between pTyr15 of Cdk3 and Cys215 of PTP1B is indicated. (C) Visualization of the complex of IR β (yellow) and PTP1B (grey). The catalytic residue Cys215 indicated in green is close to IR β pTyr1146 indicated in red. (D) Closer view of the PTP1B-IR β interaction. The distance between Cdk3 pTyr1146 and PTP1B Cys215 is indicated. (E) Visualization of the complex of DOK1 (yellow) and PTP1B (grey). The catalytic residue Cys215 indicated in green is close to DOK1 pTyr362 indicated in red. (F) Closer view of the PTP1B-DOK1 interaction. The distance between DOK1 pTyr362 and PTP1B Cys215 is indicated.(G) Visualization of the complex of EphA (yellow) and PTP1B (gray). The catalytic residue Cys215 indicated in green is close to EphA pTyr205 indicated in red. (F) Closer view of the PTP1B-EphA interaction. The distance between EphA pTyr205 and PTP1B Cys215 is indicated.

Article Snippet: The primer sequences for mutagenesis were Cdk3 AF Fwd: 5′ aagatcggagagggc g cct t tggggtggtgtacaa 3′ and Cdk3 AF Rev: 5′ ttgtacaccacccca a agg c gccctctccgatctt 3′. siRNAs targeting human PTP1B (sc-36328) and Cdk3 (sc-37578) were obtained from Santa Cruz (Dallas, TX, USA).

Techniques: Multiplex sample analysis, Phospho-proteomics, Residue

Minimal distance from the catalytic residues on PTP1B’s phosphatase domain to the phosphorous atom of its substrates

Journal: Molecular and Cellular Biology

Article Title: A PTP1B-Cdk3 Signaling Axis Promotes Cell Cycle Progression of Human Glioblastoma Cells through an Rb-E2F Dependent Pathway

doi: 10.1080/10985549.2023.2273193

Figure Lengend Snippet: Minimal distance from the catalytic residues on PTP1B’s phosphatase domain to the phosphorous atom of its substrates

Article Snippet: The primer sequences for mutagenesis were Cdk3 AF Fwd: 5′ aagatcggagagggc g cct t tggggtggtgtacaa 3′ and Cdk3 AF Rev: 5′ ttgtacaccacccca a agg c gccctctccgatctt 3′. siRNAs targeting human PTP1B (sc-36328) and Cdk3 (sc-37578) were obtained from Santa Cruz (Dallas, TX, USA).

Techniques: Ligand Binding Assay

PTP1B dephosphorylates a Cdk3 derived peptide in vitro and both proteins interact in GB cells. (A) The in vitro activity of PTP1B against a phosphopeptide corresponding to residues 9-21 of Cdk3 (KIGEGT pY GVVYKA) was determined by using a malachite-green based assay. An IR β phosphopeptide (TRDI pY ETDYYRK) was used as positive control and the nonphosphorylated peptides of Cdk3 and IR β were used as negative controls. Each assay was independently repeated with four replicates and the nmol of phosphate released were calculated. Data are presented as means ± SE. (B). Assessment of Cdk3 activity in Ptp1b +/+ and Ptp1b −/− MEFs. Cell lysates were subjected to Western blot with anti-PTP1B, anti-Cdk3 or anti-phospho Cdk3 antibodies. GAPDH was used as loading control. (C) Co-immunoprecipitation of ectopically expressed wild-type or trapping mutant PTP1B and Cdk3. Cell lysates of transfected cells incubated with or without 1 mM of sodium orthovanadate were subjected to immunoprecipitation with anti-myc or isotype control IgG antibodies and the presence of Cdk3 in the complex was assessed with anti-HA antibodies. The presence of PTP1B and Cdk3 in cell extracts prior to immunoprecipitation was verified using specific antibodies (input). (D) Co-immunoprecipitation of endogenous PTP1B and Cdk3. LN229, U87-MG and U251 cell lysates were subjected to immunoprecipitation with anti-PTP1B or isotype control IgG antibodies and the presence of Cdk3 in the complex was assessed with anti-Cdk3 antibodies. The presence of PTP1B and Cdk3 in cell extracts prior to immunoprecipitation was verified using specific antibodies (input). (E) The physical interaction between endogenously expressed PTP1B and Cdk3 in LN229, U87-MG and U251 GB cells was determined using proximity ligation assays. The figure shows representative confocal microscopy images in which PTP1B-Cdk3 interactions appear as individual fluorescent red dots (lower panels). Anti-mouse and anti-rabbit isotype IgG antibodies were used as negative controls (upper panels).

Journal: Molecular and Cellular Biology

Article Title: A PTP1B-Cdk3 Signaling Axis Promotes Cell Cycle Progression of Human Glioblastoma Cells through an Rb-E2F Dependent Pathway

doi: 10.1080/10985549.2023.2273193

Figure Lengend Snippet: PTP1B dephosphorylates a Cdk3 derived peptide in vitro and both proteins interact in GB cells. (A) The in vitro activity of PTP1B against a phosphopeptide corresponding to residues 9-21 of Cdk3 (KIGEGT pY GVVYKA) was determined by using a malachite-green based assay. An IR β phosphopeptide (TRDI pY ETDYYRK) was used as positive control and the nonphosphorylated peptides of Cdk3 and IR β were used as negative controls. Each assay was independently repeated with four replicates and the nmol of phosphate released were calculated. Data are presented as means ± SE. (B). Assessment of Cdk3 activity in Ptp1b +/+ and Ptp1b −/− MEFs. Cell lysates were subjected to Western blot with anti-PTP1B, anti-Cdk3 or anti-phospho Cdk3 antibodies. GAPDH was used as loading control. (C) Co-immunoprecipitation of ectopically expressed wild-type or trapping mutant PTP1B and Cdk3. Cell lysates of transfected cells incubated with or without 1 mM of sodium orthovanadate were subjected to immunoprecipitation with anti-myc or isotype control IgG antibodies and the presence of Cdk3 in the complex was assessed with anti-HA antibodies. The presence of PTP1B and Cdk3 in cell extracts prior to immunoprecipitation was verified using specific antibodies (input). (D) Co-immunoprecipitation of endogenous PTP1B and Cdk3. LN229, U87-MG and U251 cell lysates were subjected to immunoprecipitation with anti-PTP1B or isotype control IgG antibodies and the presence of Cdk3 in the complex was assessed with anti-Cdk3 antibodies. The presence of PTP1B and Cdk3 in cell extracts prior to immunoprecipitation was verified using specific antibodies (input). (E) The physical interaction between endogenously expressed PTP1B and Cdk3 in LN229, U87-MG and U251 GB cells was determined using proximity ligation assays. The figure shows representative confocal microscopy images in which PTP1B-Cdk3 interactions appear as individual fluorescent red dots (lower panels). Anti-mouse and anti-rabbit isotype IgG antibodies were used as negative controls (upper panels).

Article Snippet: The primer sequences for mutagenesis were Cdk3 AF Fwd: 5′ aagatcggagagggc g cct t tggggtggtgtacaa 3′ and Cdk3 AF Rev: 5′ ttgtacaccacccca a agg c gccctctccgatctt 3′. siRNAs targeting human PTP1B (sc-36328) and Cdk3 (sc-37578) were obtained from Santa Cruz (Dallas, TX, USA).

Techniques: Derivative Assay, In Vitro, Activity Assay, Phospho-proteomics, Malachite Green Assay, Positive Control, Western Blot, Control, Immunoprecipitation, Mutagenesis, Transfection, Incubation, Ligation, Confocal Microscopy

PTP1B and Cdk3 depletion impairs cell proliferation. (A) GB cells were transfected with siRNAs targeting PTP1B or Cdk3, and the expression of both proteins was assessed by immunoblot. GAPDH was used as loading control. (B) GB cells were synchronized at G0 by serum deprivation and incubated 3 h with vehicle, claramine 2 µM, trodusquemine 2 µM, or transfected with nontargeting siRNAs or siRNAs targeting PTP1B or Cdk3. Cells were counted every 24 h. Proliferation of LN229, U87-MG and U251 cells is represented as mean ± SE of three independent experiments. (C) Ptp1b +/+ and Ptp1b −/− MEFs were synchronized at G0 by serum deprivation and incubated 3 h with vehicle, claramine 2 µM, trodusquemine 2 µM. Cells were counted every 24 h. Proliferation of Ptp1b +/+ and Ptp1b −/− MEFs is represented as mean ± SE of three independent experiments.

Journal: Molecular and Cellular Biology

Article Title: A PTP1B-Cdk3 Signaling Axis Promotes Cell Cycle Progression of Human Glioblastoma Cells through an Rb-E2F Dependent Pathway

doi: 10.1080/10985549.2023.2273193

Figure Lengend Snippet: PTP1B and Cdk3 depletion impairs cell proliferation. (A) GB cells were transfected with siRNAs targeting PTP1B or Cdk3, and the expression of both proteins was assessed by immunoblot. GAPDH was used as loading control. (B) GB cells were synchronized at G0 by serum deprivation and incubated 3 h with vehicle, claramine 2 µM, trodusquemine 2 µM, or transfected with nontargeting siRNAs or siRNAs targeting PTP1B or Cdk3. Cells were counted every 24 h. Proliferation of LN229, U87-MG and U251 cells is represented as mean ± SE of three independent experiments. (C) Ptp1b +/+ and Ptp1b −/− MEFs were synchronized at G0 by serum deprivation and incubated 3 h with vehicle, claramine 2 µM, trodusquemine 2 µM. Cells were counted every 24 h. Proliferation of Ptp1b +/+ and Ptp1b −/− MEFs is represented as mean ± SE of three independent experiments.

Article Snippet: The primer sequences for mutagenesis were Cdk3 AF Fwd: 5′ aagatcggagagggc g cct t tggggtggtgtacaa 3′ and Cdk3 AF Rev: 5′ ttgtacaccacccca a agg c gccctctccgatctt 3′. siRNAs targeting human PTP1B (sc-36328) and Cdk3 (sc-37578) were obtained from Santa Cruz (Dallas, TX, USA).

Techniques: Transfection, Expressing, Western Blot, Control, Incubation

PTP1B reduced activity impairs Cdk3 activation and induces cell cycle arrest in human GB cells. GB cells were synchronized at G0 by serum deprivation for 48 h and incubated 3 h with vehicle (A), claramine 2 µM (B), or trodusquemine 2 µM. Cell cycle arrest was released by the addition of 10% FBS and cells were collected at the indicated times. The activity of Cdk3 was assessed by immunoblot. GAPDH was used as loading control. (D) GB cells were synchronized at G0 and incubated 3 h with vehicle, claramine 2 µM or trodusquemine 2 µM as previously mentioned, or transfected with nontargeting siRNAs or siRNAs targeting PTP1B or Cdk3. Cell cycle arrest was released by the addition of 10% FBS, cells were fixed at indicated time points and stained with propidium iodide. Quantification of the percentage of cells at each phase is represented. Statistical differences between control and experimental groups of cells are indicated (* P < 0.05). Data are representative of three independent experiments.

Journal: Molecular and Cellular Biology

Article Title: A PTP1B-Cdk3 Signaling Axis Promotes Cell Cycle Progression of Human Glioblastoma Cells through an Rb-E2F Dependent Pathway

doi: 10.1080/10985549.2023.2273193

Figure Lengend Snippet: PTP1B reduced activity impairs Cdk3 activation and induces cell cycle arrest in human GB cells. GB cells were synchronized at G0 by serum deprivation for 48 h and incubated 3 h with vehicle (A), claramine 2 µM (B), or trodusquemine 2 µM. Cell cycle arrest was released by the addition of 10% FBS and cells were collected at the indicated times. The activity of Cdk3 was assessed by immunoblot. GAPDH was used as loading control. (D) GB cells were synchronized at G0 and incubated 3 h with vehicle, claramine 2 µM or trodusquemine 2 µM as previously mentioned, or transfected with nontargeting siRNAs or siRNAs targeting PTP1B or Cdk3. Cell cycle arrest was released by the addition of 10% FBS, cells were fixed at indicated time points and stained with propidium iodide. Quantification of the percentage of cells at each phase is represented. Statistical differences between control and experimental groups of cells are indicated (* P < 0.05). Data are representative of three independent experiments.

Article Snippet: The primer sequences for mutagenesis were Cdk3 AF Fwd: 5′ aagatcggagagggc g cct t tggggtggtgtacaa 3′ and Cdk3 AF Rev: 5′ ttgtacaccacccca a agg c gccctctccgatctt 3′. siRNAs targeting human PTP1B (sc-36328) and Cdk3 (sc-37578) were obtained from Santa Cruz (Dallas, TX, USA).

Techniques: Activity Assay, Activation Assay, Incubation, Western Blot, Control, Transfection, Staining

PTP1B reduced activity negatively affects Cdk3/Rb/E2F signaling in human GB cells. (A) The activities of Cdk3 and Rb in GB cells treated with vehicle, claramine 2 µM or trodusquemine 2 µM were assessed by immunoblot using total and phospho-specific antibodies. (B) The activities of Cdk3 and Rb in GB cells transfected with siRNAs targeting PTP1B were assessed by immunoblot using total and phospho-specific antibodies. (C) The expression levels of the E2F target genes: Cdk1, Cyclin A, and Cyclin E1 were assessed by RT-qPCR. All data were normalized to control GAPDH. Fold changes were calculated using the ΔCt method (2 -ΔΔCt ). Data are representative of three independent experiments.

Journal: Molecular and Cellular Biology

Article Title: A PTP1B-Cdk3 Signaling Axis Promotes Cell Cycle Progression of Human Glioblastoma Cells through an Rb-E2F Dependent Pathway

doi: 10.1080/10985549.2023.2273193

Figure Lengend Snippet: PTP1B reduced activity negatively affects Cdk3/Rb/E2F signaling in human GB cells. (A) The activities of Cdk3 and Rb in GB cells treated with vehicle, claramine 2 µM or trodusquemine 2 µM were assessed by immunoblot using total and phospho-specific antibodies. (B) The activities of Cdk3 and Rb in GB cells transfected with siRNAs targeting PTP1B were assessed by immunoblot using total and phospho-specific antibodies. (C) The expression levels of the E2F target genes: Cdk1, Cyclin A, and Cyclin E1 were assessed by RT-qPCR. All data were normalized to control GAPDH. Fold changes were calculated using the ΔCt method (2 -ΔΔCt ). Data are representative of three independent experiments.

Article Snippet: The primer sequences for mutagenesis were Cdk3 AF Fwd: 5′ aagatcggagagggc g cct t tggggtggtgtacaa 3′ and Cdk3 AF Rev: 5′ ttgtacaccacccca a agg c gccctctccgatctt 3′. siRNAs targeting human PTP1B (sc-36328) and Cdk3 (sc-37578) were obtained from Santa Cruz (Dallas, TX, USA).

Techniques: Activity Assay, Western Blot, Transfection, Expressing, Quantitative RT-PCR, Control

Activated Cdk3 bypasses requirement for PTP1B for proliferation and cell cycle progression. (A) GB cells were transfected with a plasmid encoding a constitutively active Cdk3 mutant. The presence of Cdk3 AF in cell extracts was verified by Western blot using anti-HA antibodies. (B) GB cells were mock transfected or transfected with a plasmid encoding a constitutively active Cdk3 mutant and incubated 3 h with vehicle, claramine 2 µM or trodusquemine 2 µM. Cells were counted every 24 h. Proliferation of LN229, U87-MG and U251 cells is represented as mean ± SE of three independent experiments. (C) GB cells were mock transfected or transfected with a plasmid encoding a constitutively active Cdk3 mutant, synchronized at G0 and incubated 3 h with vehicle, claramine 2 µM or trodusquemine 2 µM as previously described. Cell cycle arrest was released by the addition of 10% FBS, cells were fixed at indicated time points and stained with propidium iodide. Quantification of the percentage of cells at each phase is represented in the bar graphics. Statistical differences between control and experimental groups of cells are indicated (* P < 0.05). Data are representative of three independent experiments. (D) GB cells were mock transfected or transfected with a plasmid encoding a constitutively active Cdk3 mutant, synchronized at G0 and incubated 3 h with vehicle, claramine 2 µM or trodusquemine 2 µM as previously mentioned. Cell cycle arrest was released by the addition of 10% FBS. The expression levels of the E2F target genes: Cdk1, cyclin A, and cyclin E1 were assessed by RT-qPCR. All data were normalized to control GAPDH. Fold changes were calculated using the ΔCt method (2 -ΔΔCt ). Data are representative of three independent experiments.

Journal: Molecular and Cellular Biology

Article Title: A PTP1B-Cdk3 Signaling Axis Promotes Cell Cycle Progression of Human Glioblastoma Cells through an Rb-E2F Dependent Pathway

doi: 10.1080/10985549.2023.2273193

Figure Lengend Snippet: Activated Cdk3 bypasses requirement for PTP1B for proliferation and cell cycle progression. (A) GB cells were transfected with a plasmid encoding a constitutively active Cdk3 mutant. The presence of Cdk3 AF in cell extracts was verified by Western blot using anti-HA antibodies. (B) GB cells were mock transfected or transfected with a plasmid encoding a constitutively active Cdk3 mutant and incubated 3 h with vehicle, claramine 2 µM or trodusquemine 2 µM. Cells were counted every 24 h. Proliferation of LN229, U87-MG and U251 cells is represented as mean ± SE of three independent experiments. (C) GB cells were mock transfected or transfected with a plasmid encoding a constitutively active Cdk3 mutant, synchronized at G0 and incubated 3 h with vehicle, claramine 2 µM or trodusquemine 2 µM as previously described. Cell cycle arrest was released by the addition of 10% FBS, cells were fixed at indicated time points and stained with propidium iodide. Quantification of the percentage of cells at each phase is represented in the bar graphics. Statistical differences between control and experimental groups of cells are indicated (* P < 0.05). Data are representative of three independent experiments. (D) GB cells were mock transfected or transfected with a plasmid encoding a constitutively active Cdk3 mutant, synchronized at G0 and incubated 3 h with vehicle, claramine 2 µM or trodusquemine 2 µM as previously mentioned. Cell cycle arrest was released by the addition of 10% FBS. The expression levels of the E2F target genes: Cdk1, cyclin A, and cyclin E1 were assessed by RT-qPCR. All data were normalized to control GAPDH. Fold changes were calculated using the ΔCt method (2 -ΔΔCt ). Data are representative of three independent experiments.

Article Snippet: The primer sequences for mutagenesis were Cdk3 AF Fwd: 5′ aagatcggagagggc g cct t tggggtggtgtacaa 3′ and Cdk3 AF Rev: 5′ ttgtacaccacccca a agg c gccctctccgatctt 3′. siRNAs targeting human PTP1B (sc-36328) and Cdk3 (sc-37578) were obtained from Santa Cruz (Dallas, TX, USA).

Techniques: Transfection, Plasmid Preparation, Mutagenesis, Western Blot, Incubation, Staining, Control, Expressing, Quantitative RT-PCR

Proposed model for PTP1B regulation of cell cycle. PTP1B dephosphorylates and activates Cdk3, which in turn phosphorylates Rb, favoring its dissociation from E2F and promoting the expression of genes needed for the progression to S phase.

Journal: Molecular and Cellular Biology

Article Title: A PTP1B-Cdk3 Signaling Axis Promotes Cell Cycle Progression of Human Glioblastoma Cells through an Rb-E2F Dependent Pathway

doi: 10.1080/10985549.2023.2273193

Figure Lengend Snippet: Proposed model for PTP1B regulation of cell cycle. PTP1B dephosphorylates and activates Cdk3, which in turn phosphorylates Rb, favoring its dissociation from E2F and promoting the expression of genes needed for the progression to S phase.

Article Snippet: The primer sequences for mutagenesis were Cdk3 AF Fwd: 5′ aagatcggagagggc g cct t tggggtggtgtacaa 3′ and Cdk3 AF Rev: 5′ ttgtacaccacccca a agg c gccctctccgatctt 3′. siRNAs targeting human PTP1B (sc-36328) and Cdk3 (sc-37578) were obtained from Santa Cruz (Dallas, TX, USA).

Techniques: Expressing

Identification of cell cycle related substrates of PTP1B

Journal: Molecular and Cellular Biology

Article Title: A PTP1B-Cdk3 Signaling Axis Promotes Cell Cycle Progression of Human Glioblastoma Cells through an Rb-E2F Dependent Pathway

doi: 10.1080/10985549.2023.2273193

Figure Lengend Snippet: Identification of cell cycle related substrates of PTP1B

Article Snippet: The primer sequences for mutagenesis were Cdk3 AF Fwd: 5′ aagatcggagagggc g cct t tggggtggtgtacaa 3′ and Cdk3 AF Rev: 5′ ttgtacaccacccca a agg c gccctctccgatctt 3′. siRNAs targeting human PTP1B (sc-36328) and Cdk3 (sc-37578) were obtained from Santa Cruz (Dallas, TX, USA).

Techniques: Sequencing

Predicted structure of PTP1B in complex with some of the putative substrates identified by SILAC-based phosphoproteomics. (A) Visualization of the complex of Cdk3 (yellow) and the catalytic domain of PTP1B (grey). The catalytic residue Cys215 of PTP1B and pTyr15 of Cdk are indicated in green and red, respectively. (B) Closer view of the PTP1B-Cdk3 interaction. The distance between pTyr15 of Cdk3 and Cys215 of PTP1B is indicated. (C) Visualization of the complex of IR β (yellow) and PTP1B (grey). The catalytic residue Cys215 indicated in green is close to IR β pTyr1146 indicated in red. (D) Closer view of the PTP1B-IR β interaction. The distance between Cdk3 pTyr1146 and PTP1B Cys215 is indicated. (E) Visualization of the complex of DOK1 (yellow) and PTP1B (grey). The catalytic residue Cys215 indicated in green is close to DOK1 pTyr362 indicated in red. (F) Closer view of the PTP1B-DOK1 interaction. The distance between DOK1 pTyr362 and PTP1B Cys215 is indicated.(G) Visualization of the complex of EphA (yellow) and PTP1B (gray). The catalytic residue Cys215 indicated in green is close to EphA pTyr205 indicated in red. (F) Closer view of the PTP1B-EphA interaction. The distance between EphA pTyr205 and PTP1B Cys215 is indicated.

Journal: Molecular and Cellular Biology

Article Title: A PTP1B-Cdk3 Signaling Axis Promotes Cell Cycle Progression of Human Glioblastoma Cells through an Rb-E2F Dependent Pathway

doi: 10.1080/10985549.2023.2273193

Figure Lengend Snippet: Predicted structure of PTP1B in complex with some of the putative substrates identified by SILAC-based phosphoproteomics. (A) Visualization of the complex of Cdk3 (yellow) and the catalytic domain of PTP1B (grey). The catalytic residue Cys215 of PTP1B and pTyr15 of Cdk are indicated in green and red, respectively. (B) Closer view of the PTP1B-Cdk3 interaction. The distance between pTyr15 of Cdk3 and Cys215 of PTP1B is indicated. (C) Visualization of the complex of IR β (yellow) and PTP1B (grey). The catalytic residue Cys215 indicated in green is close to IR β pTyr1146 indicated in red. (D) Closer view of the PTP1B-IR β interaction. The distance between Cdk3 pTyr1146 and PTP1B Cys215 is indicated. (E) Visualization of the complex of DOK1 (yellow) and PTP1B (grey). The catalytic residue Cys215 indicated in green is close to DOK1 pTyr362 indicated in red. (F) Closer view of the PTP1B-DOK1 interaction. The distance between DOK1 pTyr362 and PTP1B Cys215 is indicated.(G) Visualization of the complex of EphA (yellow) and PTP1B (gray). The catalytic residue Cys215 indicated in green is close to EphA pTyr205 indicated in red. (F) Closer view of the PTP1B-EphA interaction. The distance between EphA pTyr205 and PTP1B Cys215 is indicated.

Article Snippet: The primer sequences for mutagenesis were Cdk3 AF Fwd: 5′ aagatcggagagggc g cct t tggggtggtgtacaa 3′ and Cdk3 AF Rev: 5′ ttgtacaccacccca a agg c gccctctccgatctt 3′. siRNAs targeting human PTP1B (sc-36328) and Cdk3 (sc-37578) were obtained from Santa Cruz (Dallas, TX, USA).

Techniques: Multiplex sample analysis, Phospho-proteomics, Residue

Minimal distance from the catalytic residues on PTP1B’s phosphatase domain to the phosphorous atom of its substrates

Journal: Molecular and Cellular Biology

Article Title: A PTP1B-Cdk3 Signaling Axis Promotes Cell Cycle Progression of Human Glioblastoma Cells through an Rb-E2F Dependent Pathway

doi: 10.1080/10985549.2023.2273193

Figure Lengend Snippet: Minimal distance from the catalytic residues on PTP1B’s phosphatase domain to the phosphorous atom of its substrates

Article Snippet: The primer sequences for mutagenesis were Cdk3 AF Fwd: 5′ aagatcggagagggc g cct t tggggtggtgtacaa 3′ and Cdk3 AF Rev: 5′ ttgtacaccacccca a agg c gccctctccgatctt 3′. siRNAs targeting human PTP1B (sc-36328) and Cdk3 (sc-37578) were obtained from Santa Cruz (Dallas, TX, USA).

Techniques: Ligand Binding Assay

PTP1B dephosphorylates a Cdk3 derived peptide in vitro and both proteins interact in GB cells. (A) The in vitro activity of PTP1B against a phosphopeptide corresponding to residues 9-21 of Cdk3 (KIGEGT pY GVVYKA) was determined by using a malachite-green based assay. An IR β phosphopeptide (TRDI pY ETDYYRK) was used as positive control and the nonphosphorylated peptides of Cdk3 and IR β were used as negative controls. Each assay was independently repeated with four replicates and the nmol of phosphate released were calculated. Data are presented as means ± SE. (B). Assessment of Cdk3 activity in Ptp1b +/+ and Ptp1b −/− MEFs. Cell lysates were subjected to Western blot with anti-PTP1B, anti-Cdk3 or anti-phospho Cdk3 antibodies. GAPDH was used as loading control. (C) Co-immunoprecipitation of ectopically expressed wild-type or trapping mutant PTP1B and Cdk3. Cell lysates of transfected cells incubated with or without 1 mM of sodium orthovanadate were subjected to immunoprecipitation with anti-myc or isotype control IgG antibodies and the presence of Cdk3 in the complex was assessed with anti-HA antibodies. The presence of PTP1B and Cdk3 in cell extracts prior to immunoprecipitation was verified using specific antibodies (input). (D) Co-immunoprecipitation of endogenous PTP1B and Cdk3. LN229, U87-MG and U251 cell lysates were subjected to immunoprecipitation with anti-PTP1B or isotype control IgG antibodies and the presence of Cdk3 in the complex was assessed with anti-Cdk3 antibodies. The presence of PTP1B and Cdk3 in cell extracts prior to immunoprecipitation was verified using specific antibodies (input). (E) The physical interaction between endogenously expressed PTP1B and Cdk3 in LN229, U87-MG and U251 GB cells was determined using proximity ligation assays. The figure shows representative confocal microscopy images in which PTP1B-Cdk3 interactions appear as individual fluorescent red dots (lower panels). Anti-mouse and anti-rabbit isotype IgG antibodies were used as negative controls (upper panels).

Journal: Molecular and Cellular Biology

Article Title: A PTP1B-Cdk3 Signaling Axis Promotes Cell Cycle Progression of Human Glioblastoma Cells through an Rb-E2F Dependent Pathway

doi: 10.1080/10985549.2023.2273193

Figure Lengend Snippet: PTP1B dephosphorylates a Cdk3 derived peptide in vitro and both proteins interact in GB cells. (A) The in vitro activity of PTP1B against a phosphopeptide corresponding to residues 9-21 of Cdk3 (KIGEGT pY GVVYKA) was determined by using a malachite-green based assay. An IR β phosphopeptide (TRDI pY ETDYYRK) was used as positive control and the nonphosphorylated peptides of Cdk3 and IR β were used as negative controls. Each assay was independently repeated with four replicates and the nmol of phosphate released were calculated. Data are presented as means ± SE. (B). Assessment of Cdk3 activity in Ptp1b +/+ and Ptp1b −/− MEFs. Cell lysates were subjected to Western blot with anti-PTP1B, anti-Cdk3 or anti-phospho Cdk3 antibodies. GAPDH was used as loading control. (C) Co-immunoprecipitation of ectopically expressed wild-type or trapping mutant PTP1B and Cdk3. Cell lysates of transfected cells incubated with or without 1 mM of sodium orthovanadate were subjected to immunoprecipitation with anti-myc or isotype control IgG antibodies and the presence of Cdk3 in the complex was assessed with anti-HA antibodies. The presence of PTP1B and Cdk3 in cell extracts prior to immunoprecipitation was verified using specific antibodies (input). (D) Co-immunoprecipitation of endogenous PTP1B and Cdk3. LN229, U87-MG and U251 cell lysates were subjected to immunoprecipitation with anti-PTP1B or isotype control IgG antibodies and the presence of Cdk3 in the complex was assessed with anti-Cdk3 antibodies. The presence of PTP1B and Cdk3 in cell extracts prior to immunoprecipitation was verified using specific antibodies (input). (E) The physical interaction between endogenously expressed PTP1B and Cdk3 in LN229, U87-MG and U251 GB cells was determined using proximity ligation assays. The figure shows representative confocal microscopy images in which PTP1B-Cdk3 interactions appear as individual fluorescent red dots (lower panels). Anti-mouse and anti-rabbit isotype IgG antibodies were used as negative controls (upper panels).

Article Snippet: The primer sequences for mutagenesis were Cdk3 AF Fwd: 5′ aagatcggagagggc g cct t tggggtggtgtacaa 3′ and Cdk3 AF Rev: 5′ ttgtacaccacccca a agg c gccctctccgatctt 3′. siRNAs targeting human PTP1B (sc-36328) and Cdk3 (sc-37578) were obtained from Santa Cruz (Dallas, TX, USA).

Techniques: Derivative Assay, In Vitro, Activity Assay, Phospho-proteomics, Malachite Green Assay, Positive Control, Western Blot, Control, Immunoprecipitation, Mutagenesis, Transfection, Incubation, Ligation, Confocal Microscopy

PTP1B and Cdk3 depletion impairs cell proliferation. (A) GB cells were transfected with siRNAs targeting PTP1B or Cdk3, and the expression of both proteins was assessed by immunoblot. GAPDH was used as loading control. (B) GB cells were synchronized at G0 by serum deprivation and incubated 3 h with vehicle, claramine 2 µM, trodusquemine 2 µM, or transfected with nontargeting siRNAs or siRNAs targeting PTP1B or Cdk3. Cells were counted every 24 h. Proliferation of LN229, U87-MG and U251 cells is represented as mean ± SE of three independent experiments. (C) Ptp1b +/+ and Ptp1b −/− MEFs were synchronized at G0 by serum deprivation and incubated 3 h with vehicle, claramine 2 µM, trodusquemine 2 µM. Cells were counted every 24 h. Proliferation of Ptp1b +/+ and Ptp1b −/− MEFs is represented as mean ± SE of three independent experiments.

Journal: Molecular and Cellular Biology

Article Title: A PTP1B-Cdk3 Signaling Axis Promotes Cell Cycle Progression of Human Glioblastoma Cells through an Rb-E2F Dependent Pathway

doi: 10.1080/10985549.2023.2273193

Figure Lengend Snippet: PTP1B and Cdk3 depletion impairs cell proliferation. (A) GB cells were transfected with siRNAs targeting PTP1B or Cdk3, and the expression of both proteins was assessed by immunoblot. GAPDH was used as loading control. (B) GB cells were synchronized at G0 by serum deprivation and incubated 3 h with vehicle, claramine 2 µM, trodusquemine 2 µM, or transfected with nontargeting siRNAs or siRNAs targeting PTP1B or Cdk3. Cells were counted every 24 h. Proliferation of LN229, U87-MG and U251 cells is represented as mean ± SE of three independent experiments. (C) Ptp1b +/+ and Ptp1b −/− MEFs were synchronized at G0 by serum deprivation and incubated 3 h with vehicle, claramine 2 µM, trodusquemine 2 µM. Cells were counted every 24 h. Proliferation of Ptp1b +/+ and Ptp1b −/− MEFs is represented as mean ± SE of three independent experiments.

Article Snippet: The primer sequences for mutagenesis were Cdk3 AF Fwd: 5′ aagatcggagagggc g cct t tggggtggtgtacaa 3′ and Cdk3 AF Rev: 5′ ttgtacaccacccca a agg c gccctctccgatctt 3′. siRNAs targeting human PTP1B (sc-36328) and Cdk3 (sc-37578) were obtained from Santa Cruz (Dallas, TX, USA).

Techniques: Transfection, Expressing, Western Blot, Control, Incubation

PTP1B reduced activity impairs Cdk3 activation and induces cell cycle arrest in human GB cells. GB cells were synchronized at G0 by serum deprivation for 48 h and incubated 3 h with vehicle (A), claramine 2 µM (B), or trodusquemine 2 µM. Cell cycle arrest was released by the addition of 10% FBS and cells were collected at the indicated times. The activity of Cdk3 was assessed by immunoblot. GAPDH was used as loading control. (D) GB cells were synchronized at G0 and incubated 3 h with vehicle, claramine 2 µM or trodusquemine 2 µM as previously mentioned, or transfected with nontargeting siRNAs or siRNAs targeting PTP1B or Cdk3. Cell cycle arrest was released by the addition of 10% FBS, cells were fixed at indicated time points and stained with propidium iodide. Quantification of the percentage of cells at each phase is represented. Statistical differences between control and experimental groups of cells are indicated (* P < 0.05). Data are representative of three independent experiments.

Journal: Molecular and Cellular Biology

Article Title: A PTP1B-Cdk3 Signaling Axis Promotes Cell Cycle Progression of Human Glioblastoma Cells through an Rb-E2F Dependent Pathway

doi: 10.1080/10985549.2023.2273193

Figure Lengend Snippet: PTP1B reduced activity impairs Cdk3 activation and induces cell cycle arrest in human GB cells. GB cells were synchronized at G0 by serum deprivation for 48 h and incubated 3 h with vehicle (A), claramine 2 µM (B), or trodusquemine 2 µM. Cell cycle arrest was released by the addition of 10% FBS and cells were collected at the indicated times. The activity of Cdk3 was assessed by immunoblot. GAPDH was used as loading control. (D) GB cells were synchronized at G0 and incubated 3 h with vehicle, claramine 2 µM or trodusquemine 2 µM as previously mentioned, or transfected with nontargeting siRNAs or siRNAs targeting PTP1B or Cdk3. Cell cycle arrest was released by the addition of 10% FBS, cells were fixed at indicated time points and stained with propidium iodide. Quantification of the percentage of cells at each phase is represented. Statistical differences between control and experimental groups of cells are indicated (* P < 0.05). Data are representative of three independent experiments.

Article Snippet: The primer sequences for mutagenesis were Cdk3 AF Fwd: 5′ aagatcggagagggc g cct t tggggtggtgtacaa 3′ and Cdk3 AF Rev: 5′ ttgtacaccacccca a agg c gccctctccgatctt 3′. siRNAs targeting human PTP1B (sc-36328) and Cdk3 (sc-37578) were obtained from Santa Cruz (Dallas, TX, USA).

Techniques: Activity Assay, Activation Assay, Incubation, Western Blot, Control, Transfection, Staining

PTP1B reduced activity negatively affects Cdk3/Rb/E2F signaling in human GB cells. (A) The activities of Cdk3 and Rb in GB cells treated with vehicle, claramine 2 µM or trodusquemine 2 µM were assessed by immunoblot using total and phospho-specific antibodies. (B) The activities of Cdk3 and Rb in GB cells transfected with siRNAs targeting PTP1B were assessed by immunoblot using total and phospho-specific antibodies. (C) The expression levels of the E2F target genes: Cdk1, Cyclin A, and Cyclin E1 were assessed by RT-qPCR. All data were normalized to control GAPDH. Fold changes were calculated using the ΔCt method (2 -ΔΔCt ). Data are representative of three independent experiments.

Journal: Molecular and Cellular Biology

Article Title: A PTP1B-Cdk3 Signaling Axis Promotes Cell Cycle Progression of Human Glioblastoma Cells through an Rb-E2F Dependent Pathway

doi: 10.1080/10985549.2023.2273193

Figure Lengend Snippet: PTP1B reduced activity negatively affects Cdk3/Rb/E2F signaling in human GB cells. (A) The activities of Cdk3 and Rb in GB cells treated with vehicle, claramine 2 µM or trodusquemine 2 µM were assessed by immunoblot using total and phospho-specific antibodies. (B) The activities of Cdk3 and Rb in GB cells transfected with siRNAs targeting PTP1B were assessed by immunoblot using total and phospho-specific antibodies. (C) The expression levels of the E2F target genes: Cdk1, Cyclin A, and Cyclin E1 were assessed by RT-qPCR. All data were normalized to control GAPDH. Fold changes were calculated using the ΔCt method (2 -ΔΔCt ). Data are representative of three independent experiments.

Article Snippet: The primer sequences for mutagenesis were Cdk3 AF Fwd: 5′ aagatcggagagggc g cct t tggggtggtgtacaa 3′ and Cdk3 AF Rev: 5′ ttgtacaccacccca a agg c gccctctccgatctt 3′. siRNAs targeting human PTP1B (sc-36328) and Cdk3 (sc-37578) were obtained from Santa Cruz (Dallas, TX, USA).

Techniques: Activity Assay, Western Blot, Transfection, Expressing, Quantitative RT-PCR, Control

Activated Cdk3 bypasses requirement for PTP1B for proliferation and cell cycle progression. (A) GB cells were transfected with a plasmid encoding a constitutively active Cdk3 mutant. The presence of Cdk3 AF in cell extracts was verified by Western blot using anti-HA antibodies. (B) GB cells were mock transfected or transfected with a plasmid encoding a constitutively active Cdk3 mutant and incubated 3 h with vehicle, claramine 2 µM or trodusquemine 2 µM. Cells were counted every 24 h. Proliferation of LN229, U87-MG and U251 cells is represented as mean ± SE of three independent experiments. (C) GB cells were mock transfected or transfected with a plasmid encoding a constitutively active Cdk3 mutant, synchronized at G0 and incubated 3 h with vehicle, claramine 2 µM or trodusquemine 2 µM as previously described. Cell cycle arrest was released by the addition of 10% FBS, cells were fixed at indicated time points and stained with propidium iodide. Quantification of the percentage of cells at each phase is represented in the bar graphics. Statistical differences between control and experimental groups of cells are indicated (* P < 0.05). Data are representative of three independent experiments. (D) GB cells were mock transfected or transfected with a plasmid encoding a constitutively active Cdk3 mutant, synchronized at G0 and incubated 3 h with vehicle, claramine 2 µM or trodusquemine 2 µM as previously mentioned. Cell cycle arrest was released by the addition of 10% FBS. The expression levels of the E2F target genes: Cdk1, cyclin A, and cyclin E1 were assessed by RT-qPCR. All data were normalized to control GAPDH. Fold changes were calculated using the ΔCt method (2 -ΔΔCt ). Data are representative of three independent experiments.

Journal: Molecular and Cellular Biology

Article Title: A PTP1B-Cdk3 Signaling Axis Promotes Cell Cycle Progression of Human Glioblastoma Cells through an Rb-E2F Dependent Pathway

doi: 10.1080/10985549.2023.2273193

Figure Lengend Snippet: Activated Cdk3 bypasses requirement for PTP1B for proliferation and cell cycle progression. (A) GB cells were transfected with a plasmid encoding a constitutively active Cdk3 mutant. The presence of Cdk3 AF in cell extracts was verified by Western blot using anti-HA antibodies. (B) GB cells were mock transfected or transfected with a plasmid encoding a constitutively active Cdk3 mutant and incubated 3 h with vehicle, claramine 2 µM or trodusquemine 2 µM. Cells were counted every 24 h. Proliferation of LN229, U87-MG and U251 cells is represented as mean ± SE of three independent experiments. (C) GB cells were mock transfected or transfected with a plasmid encoding a constitutively active Cdk3 mutant, synchronized at G0 and incubated 3 h with vehicle, claramine 2 µM or trodusquemine 2 µM as previously described. Cell cycle arrest was released by the addition of 10% FBS, cells were fixed at indicated time points and stained with propidium iodide. Quantification of the percentage of cells at each phase is represented in the bar graphics. Statistical differences between control and experimental groups of cells are indicated (* P < 0.05). Data are representative of three independent experiments. (D) GB cells were mock transfected or transfected with a plasmid encoding a constitutively active Cdk3 mutant, synchronized at G0 and incubated 3 h with vehicle, claramine 2 µM or trodusquemine 2 µM as previously mentioned. Cell cycle arrest was released by the addition of 10% FBS. The expression levels of the E2F target genes: Cdk1, cyclin A, and cyclin E1 were assessed by RT-qPCR. All data were normalized to control GAPDH. Fold changes were calculated using the ΔCt method (2 -ΔΔCt ). Data are representative of three independent experiments.

Article Snippet: The primer sequences for mutagenesis were Cdk3 AF Fwd: 5′ aagatcggagagggc g cct t tggggtggtgtacaa 3′ and Cdk3 AF Rev: 5′ ttgtacaccacccca a agg c gccctctccgatctt 3′. siRNAs targeting human PTP1B (sc-36328) and Cdk3 (sc-37578) were obtained from Santa Cruz (Dallas, TX, USA).

Techniques: Transfection, Plasmid Preparation, Mutagenesis, Western Blot, Incubation, Staining, Control, Expressing, Quantitative RT-PCR

Proposed model for PTP1B regulation of cell cycle. PTP1B dephosphorylates and activates Cdk3, which in turn phosphorylates Rb, favoring its dissociation from E2F and promoting the expression of genes needed for the progression to S phase.

Journal: Molecular and Cellular Biology

Article Title: A PTP1B-Cdk3 Signaling Axis Promotes Cell Cycle Progression of Human Glioblastoma Cells through an Rb-E2F Dependent Pathway

doi: 10.1080/10985549.2023.2273193

Figure Lengend Snippet: Proposed model for PTP1B regulation of cell cycle. PTP1B dephosphorylates and activates Cdk3, which in turn phosphorylates Rb, favoring its dissociation from E2F and promoting the expression of genes needed for the progression to S phase.

Article Snippet: The primer sequences for mutagenesis were Cdk3 AF Fwd: 5′ aagatcggagagggc g cct t tggggtggtgtacaa 3′ and Cdk3 AF Rev: 5′ ttgtacaccacccca a agg c gccctctccgatctt 3′. siRNAs targeting human PTP1B (sc-36328) and Cdk3 (sc-37578) were obtained from Santa Cruz (Dallas, TX, USA).

Techniques: Expressing